BioPharma

10 November, 2026 | Tuesday | News

10 APAC Biomanufacturing Plants Scheduled to Come Online Before End-2027, and How Many Have Already Slipped

Every capacity plan written in an Asian biopharma company this quarter rests on a calendar it did not write. Somewhere in the spreadsheet is an assumption that a new plant in Songdo, Tuas, Yokohama or Toyama wi...

Lab

11 November, 2026 | Wednesday | News

Pierre Fabre and XtalPi Partner on AI-Driven Oncology Drug Discovery

Laboratoires Pierre Fabre and XtalPi (XtalPi Holdings Limited, 2228.HK) are pleased to announce an agreement under which they will collaborate on the discovery of novel clinical candidates across a number of re...

BioTech

10 November, 2026 | Tuesday | News

KaliVir’s VET3-TGI Regimens Show 71% Response Rate in Advanced Skin Cancers in Early Trial

Preliminary data from intratumoral VET3-TGI presented in oral session at SITC 2026; abstract recognized among SITC’s top 150 abstracts Responses observed in non-injected lesions, suggesting systemic an...

Contract Services

04 November, 2026 | Wednesday | News

Lonza to Acquire Five US CDMO Sites from Merck KGaA to Double Manufacturing Footprint

Lonza acquires five CDMO manufacturing sites and approximately 1,100 highly skilled employees, more than doubling its US footprint to nine CDMO sites with a US workforce of more than 6,000 employees. Transac...

Consumer Health

06 November, 2026 | Friday | News

Abbott and Novo Expand Collaboration to Broaden Semaglutide Access Across Asia Pacific

The collaboration combines Novo's leadership in diabetes care medicines and GLP-1 therapies with Abbott's extensive healthcare and commercial footprint across the region Abbott will promote and distribute Pl...

Medtech

11 November, 2026 | Wednesday | News

ZEISS Showcases China-Approved PT LUNANA Lens for Myopia at CIIE

ZEISS Medical Technology showcased at CIIE its next-generation aspheric phakic intraocular lens (pIOL) PT LUNANA® to address myopia in China, a growing major public health challenge for the region. Resea...

Cell & Gene

23 October, 2026 | Friday | News

Therakos Secures EU MDR Approval for First-of-Its-Kind Therapy to Manage Cancer Immunotherapy Toxicities

Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced that its THERAKOS™ CELLEX™ Photopheresis Sys...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close